These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 31264551)
1. Positive Association Between Plasma Levels of Advanced Glycation and Precursor of Lipoxidation end Products with Gastrointestinal Problems in Children with Autism. Ghodsi R; Kheirouri S Curr Pediatr Rev; 2019; 15(3):184-190. PubMed ID: 31264551 [TBL] [Abstract][Full Text] [Related]
2. Carnosine supplementation does not affect serum concentrations of advanced glycation and precursors of lipoxidation end products in autism: a randomized controlled clinical trial. Ghodsi R; Kheirouri S; Nosrati R Ann Clin Biochem; 2019 Jan; 56(1):148-154. PubMed ID: 30089410 [TBL] [Abstract][Full Text] [Related]
3. Advanced glycation endproducts, dityrosine and arginine transporter dysfunction in autism - a source of biomarkers for clinical diagnosis. Anwar A; Abruzzo PM; Pasha S; Rajpoot K; Bolotta A; Ghezzo A; Marini M; Posar A; Visconti P; Thornalley PJ; Rabbani N Mol Autism; 2018; 9():3. PubMed ID: 29479405 [TBL] [Abstract][Full Text] [Related]
4. Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation. Vistoli G; De Maddis D; Cipak A; Zarkovic N; Carini M; Aldini G Free Radic Res; 2013 Aug; 47 Suppl 1():3-27. PubMed ID: 23767955 [TBL] [Abstract][Full Text] [Related]
5. Advanced glycation endproducts and its receptor for advanced glycation endproducts in obesity. Gaens KH; Stehouwer CD; Schalkwijk CG Curr Opin Lipidol; 2013 Feb; 24(1):4-11. PubMed ID: 23298958 [TBL] [Abstract][Full Text] [Related]
6. Validation of plasma protein glycation and oxidation biomarkers for the diagnosis of autism. Al-Saei ANJM; Nour-Eldine W; Rajpoot K; Arshad N; Al-Shammari AR; Kamal M; Akil AA; Fakhro KA; Thornalley PJ; Rabbani N Mol Psychiatry; 2024 Mar; 29(3):653-659. PubMed ID: 38135754 [TBL] [Abstract][Full Text] [Related]
7. Oxidative Stress and Advanced Lipoxidation and Glycation End Products (ALEs and AGEs) in Aging and Age-Related Diseases. Moldogazieva NT; Mokhosoev IM; Mel'nikova TI; Porozov YB; Terentiev AA Oxid Med Cell Longev; 2019; 2019():3085756. PubMed ID: 31485289 [TBL] [Abstract][Full Text] [Related]
8. Advanced lipoxidation end products (ALEs) as RAGE binders: Mass spectrometric and computational studies to explain the reasons why. Mol M; Degani G; Coppa C; Baron G; Popolo L; Carini M; Aldini G; Vistoli G; Altomare A Redox Biol; 2019 May; 23():101083. PubMed ID: 30598328 [TBL] [Abstract][Full Text] [Related]
9. Reduced levels of plasma polyunsaturated fatty acids and serum carnitine in autistic children: relation to gastrointestinal manifestations. Mostafa GA; Al-Ayadhi LY Behav Brain Funct; 2015 Feb; 11():4. PubMed ID: 25757041 [TBL] [Abstract][Full Text] [Related]
10. Lipoxidation in cardiovascular diseases. Gianazza E; Brioschi M; Fernandez AM; Banfi C Redox Biol; 2019 May; 23():101119. PubMed ID: 30833142 [TBL] [Abstract][Full Text] [Related]
11. Aldose reductase (AKR1B3) regulates the accumulation of advanced glycosylation end products (AGEs) and the expression of AGE receptor (RAGE). Baba SP; Hellmann J; Srivastava S; Bhatnagar A Chem Biol Interact; 2011 May; 191(1-3):357-63. PubMed ID: 21276777 [TBL] [Abstract][Full Text] [Related]
12. Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications. Miyata T; van Ypersele de Strihou C; Kurokawa K; Baynes JW Kidney Int; 1999 Feb; 55(2):389-99. PubMed ID: 9987064 [TBL] [Abstract][Full Text] [Related]
14. Glycoxidation and lipoxidation in atherogenesis. Baynes JW; Thorpe SR Free Radic Biol Med; 2000 Jun; 28(12):1708-16. PubMed ID: 10946212 [TBL] [Abstract][Full Text] [Related]
15. Reaction of pyridoxamine with malondialdehyde: mechanism of inhibition of formation of advanced lipoxidation end-products. Kang Z; Li H; Li G; Yin D Amino Acids; 2006 Feb; 30(1):55-61. PubMed ID: 15990947 [TBL] [Abstract][Full Text] [Related]
16. High Plasmatic Levels of Advanced Glycation End Products are Associated with Metabolic Alterations and Insulin Resistance in Preeclamptic Women. García-Gómez E; Bobadilla-Bravo M; Díaz-Díaz E; Vázquez-Martínez ER; Nava-Salazar S; Torres-Ramos Y; García-Romero CS; Camacho-Arroyo I; Cerbón M Curr Mol Med; 2020; 20(9):751-759. PubMed ID: 32077826 [TBL] [Abstract][Full Text] [Related]
17. Proinflammatory effects of advanced lipoxidation end products in monocytes. Shanmugam N; Figarola JL; Li Y; Swiderski PM; Rahbar S; Natarajan R Diabetes; 2008 Apr; 57(4):879-88. PubMed ID: 18003754 [TBL] [Abstract][Full Text] [Related]
18. Plasma levels of serotonin, gastrointestinal symptoms,and sleep problems in children with autism. Kheirouri S; Kalejahi P; Noorazar SG Turk J Med Sci; 2016 Dec; 46(6):1765-1772. PubMed ID: 28081325 [TBL] [Abstract][Full Text] [Related]
19. Hyperlipidemia-Mediated Increased Advanced Lipoxidation End Products Formation, an Important Factor Associated with Decreased Erythrocyte Glucose-6-Phosphate Dehydrogenase Activity in Mild Nonproliferative Diabetic Retinopathy. Choudhuri S; Roy PK; Mitra B; Sen S; Sarkar R; Das M; Biswas D; Ghosh P; Biswas A; Chakraborty S; Mondal LK Can J Diabetes; 2017 Feb; 41(1):82-89. PubMed ID: 27916496 [TBL] [Abstract][Full Text] [Related]
20. Values of markers of early and advanced glycation and lipoxidation in serum proteins of children with diabetes mellitus. Jakus V; Bauerova K; Michalkova D; Carsky J Bratisl Lek Listy; 2000; 101(9):484-9. PubMed ID: 11187050 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]